Simon Kerry, PhD MBA
Chief Executive Officer
A co-founder of Curve, Simon is an experienced life-science entrepreneur with over 30 years in leadership roles within European biotechnology companies. He has been an Operating Partner at Advent Life Sciences, a leading trans-Atlantic venture investor, since 2017.
Prior to joining Advent, Simon was CEO of cancer drug discovery company Karus Therapeutics (Oxford, UK), leading the company from spin-out to clinic. Before Karus, Simon led the Business Development functions at Ablynx (Ghent, Belgium), Active Biotech (Lund, Sweden) and Isogenica (Cambridge, UK).
Following a first degree in Medicinal and Pharmaceutical Chemistry (1984), Simon began his career as a chemist at GD Searle (High Wycombe, UK). He completed a life-science PhD in 1989 and obtained an Executive MBA from Loughborough University Business School in 1995.
Curve is backed by two knowledgeable and highly respected transatlantic life-science venture firms. Advent Life Sciences has a long-standing track-record of entrepreneurial and investment success, turning break-through science into approved medicines and medical products. Epidarex Capital invests in early-stage, high growth life science and health technology companies in emerging and under-ventured research hubs in the UK and US.